Bank Of America Corp Cytokinetics Inc Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Bank Of America Corp holds 219,121 shares of CYTK stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
219,121
Previous 4,829,423
95.46%
Holding current value
$10.1 Million
Previous $255 Million
95.96%
% of portfolio
0.0%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$675 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$548 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$495 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$363 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$284 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.33B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...